These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


298 related items for PubMed ID: 8253707

  • 1. New antidepressants: use in high-risk patients.
    Hale AS.
    J Clin Psychiatry; 1993 Aug; 54 Suppl():61-70; discussion 71-3. PubMed ID: 8253707
    [Abstract] [Full Text] [Related]

  • 2. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP, Gleiter CH, Möller HJ.
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [Abstract] [Full Text] [Related]

  • 3. [Moclobemide].
    Gleiter C, Volz HP.
    Dtsch Med Wochenschr; 1995 Aug 25; 120(34-35):1175-6. PubMed ID: 7656852
    [No Abstract] [Full Text] [Related]

  • 4. Acute therapy of depression.
    Bech P.
    J Clin Psychiatry; 1993 Aug 25; 54 Suppl():18-27; discussion 28. PubMed ID: 8253702
    [Abstract] [Full Text] [Related]

  • 5. Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
    Philipp M, Tiller JW, Baier D, Kohnen R.
    Eur Neuropsychopharmacol; 2000 Sep 25; 10(5):305-14. PubMed ID: 10974600
    [Abstract] [Full Text] [Related]

  • 6. Moclobemide. An update of its pharmacological properties and therapeutic use.
    Fulton B, Benfield P.
    Drugs; 1996 Sep 25; 52(3):450-74. PubMed ID: 8875133
    [Abstract] [Full Text] [Related]

  • 7. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
    Norman TR, Burrows GD.
    Drug Saf; 1995 Jan 25; 12(1):46-54. PubMed ID: 7741983
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M, Nardi AE, Figueira IL, Stabl M.
    Acta Psychiatr Scand Suppl; 1990 Jan 25; 360():24-8. PubMed ID: 2123366
    [Abstract] [Full Text] [Related]

  • 11. [Multicenter study comparing efficacy and tolerance of moclobemide and fluvoxamine in hospitalized and ambulatory patients with severe depressive episodes].
    Barrelet L, Blajev B, Bolzani L, de Saussure C, Kasas A, Van H, Gachoud JP.
    Schweiz Rundsch Med Prax; 1991 May 07; 80(19):524-8. PubMed ID: 1904620
    [Abstract] [Full Text] [Related]

  • 12. Moclobemide: therapeutic use and clinical studies.
    Bonnet U.
    CNS Drug Rev; 2003 May 07; 9(1):97-140. PubMed ID: 12595913
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
    Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM.
    J Clin Psychiatry; 2000 Apr 07; 61(4):276-81. PubMed ID: 10830148
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.